Why the term ‘low-grade ductal carcinoma in situ’’ should be changed to ‘borderline breast disease’’: diagnostic and clinical implications

Author： Masood Shahla  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.8, Iss.1, 2012-01, pp. : 57-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

‘Ductal Carcinoma In Situ of the Breast’ – Is It Time to Replace This Term by ‘Ductal Intraepithelial Neoplasia of the Breast’?

By  

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 218-218

Karger

Access to resources Recommend Favorite

Ductal Carcinoma in situ of the Breast: Diagnosis and Management

By  

Oncology Research and Treatment, Vol. 26, Iss. 6, 2004-01 ,pp. : 588-595

Karger

Access to resources Recommend Favorite

Immunohistochemical study of endometrial high‐grade endometrioid carcinoma with or without a concurrent low‐grade component: implications for pathogenetic and survival differences

By  

HISTOPATHOLOGY, Vol. 67, Iss. 4, 2015-10 ,pp. : 474-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immunohistochemical study of endometrial high‐grade endometrioid carcinoma with or without a concurrent low‐grade component: implications for pathogenetic and survival differences

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 4, 2015-10 ,pp. : 474-482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ductal carcinoma in situ of the breast: 11 reasons to consider treatment with excision alone

By Silverstein Melvin J  

Women's Health, Vol. 4, Iss. 6, 2008-11 ,pp. : 565-577

Future Medicine

Access to resources Recommend Favorite